Vulnerability Description
An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
CVSS Score
8.8
HIGH
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Supremainc | Biostar 2 | < 2.9.1 |
Related Weaknesses (CWE)
References
- https://claroty.com/team82/disclosure-dashboard/cve-2023-33364Third Party Advisory
- https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291Release NotesVendor Advisory
- https://claroty.com/team82/disclosure-dashboard/cve-2023-33364Third Party Advisory
- https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291Release NotesVendor Advisory
FAQ
What is CVE-2023-33364?
CVE-2023-33364 is a vulnerability with a CVSS score of 8.8 (HIGH). An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
How severe is CVE-2023-33364?
CVE-2023-33364 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2023-33364?
Check the references section above for vendor advisories and patch information. Affected products include: Supremainc Biostar 2.